A high-throughput drug screening platform uses DNA nanoswitches to identify compounds capable of changing how proteins ...
The human pangenome improved somatic mutation detection, revealing thousands of candidate mutations in a melanoma cell line.
A massive dataset created from routine has revealed how different patients share the same T-cell receptors against different cancers, providing a potential route to new immunotherapies.
An Australian study suggests a supervised food challenge may be the best way to diagnose peanut allergy in young children.
Dyve Biosciences targets acidic microenvironments in cancer and inflammatory conditions through transdermal delivery.
Researchers identify a genetic vulnerability that could enable safer WNT-targeted cancer therapies while sparing healthy ...
Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...
Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...
Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...
Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...
Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...
A 12-year study of more than 52,000 women finds no increased cardiovascular risk with modern hormone replacement therapy started during midlife.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results